arginyl-glycyl-aspartic acid has been researched along with Chronic Illness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amemori, T; Burian, M; Hájek, M; Hejcl, A; Jendelová, P; Kapcalová, M; Krumbholcová, E; Lesný, P; Likavcanová-Mašínová, K; Michálek, J; Prádný, M; Sedý, J; Syková, E; Toro, DA | 1 |
| Kaplan, RJ; McGill, JB; Prendergast, JJ; Ricotta, JJ; Schwartz, SL; Steed, DL; Webster, MW | 1 |
| Eckman, JR; Koshy, M; Phillips, G; Prchal, JT; Ramirez, GM; Siegel, RS; Steinberg, MH; Wethers, DL | 1 |
2 trial(s) available for arginyl-glycyl-aspartic acid and Chronic Illness
| Article | Year |
|---|---|
Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Chronic Disease; Data Interpretation, Statistical; Diabetic Foot; Double-Blind Method; Female; Humans; Male; Middle Aged; Oligopeptides; Wound Healing | 1995 |
Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group.
Topics: Adolescent; Adult; Aged; Anemia, Sickle Cell; Chronic Disease; Double-Blind Method; Extracellular Matrix; Female; Humans; Leg Ulcer; Male; Middle Aged; Oligopeptides; Prospective Studies | 1994 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Chronic Illness
| Article | Year |
|---|---|
HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury.
Topics: Animals; Behavior, Animal; Chronic Disease; Humans; Hydrogels; Implants, Experimental; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methacrylates; Nerve Regeneration; Oligopeptides; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Treatment Outcome | 2010 |